UFIS-SWE-IG
0.1.0 - ci-build
UFIS-SWE-IG
0.1.0 - ci-build
UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions
<Bundle xmlns="http://hl7.org/fhir">
<id value="VentilastinNovolizer100mginhaspul-SE-PLC-MPD-BBDL"/>
<type value="collection"/>
<entry>
<fullUrl
value="https://hl7-eu.github.io/unicom-ig/branches/mpd-r4b/MedicinalProductDefinition/VentilastinNovolizer100mginhaspul-SE-PLC-MPD"/>
<resource>
<MedicinalProductDefinition>
<id value="VentilastinNovolizer100mginhaspul-SE-PLC-MPD"/>
<meta>
<profile
value="http://unicom-project.eu/fhir/StructureDefinition/PPLMedicinalProductDefinition"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="MedicinalProductDefinition_VentilastinNovolizer100mginhaspul-SE-PLC-MPD"> </a><p class="res-header-id"><b>Generated Narrative: MedicinalProductDefinition VentilastinNovolizer100mginhaspul-SE-PLC-MPD</b></p><a name="VentilastinNovolizer100mginhaspul-SE-PLC-MPD"> </a><a name="hcVentilastinNovolizer100mginhaspul-SE-PLC-MPD"> </a><a name="hcVentilastinNovolizer100mginhaspul-SE-PLC-MPD-en-US"> </a><p><b>identifier</b>: <code>http://ema.europa.eu/fhir/mpId</code>/SE-100001594-00012324, <code>http://ema.europa.eu/fhir/eurdId</code>/10330</p><p><b>domain</b>: <span title="Codes:{https://spor.ema.europa.eu/v1/lists/100000000004 100000000012}">Human use</span></p><p><b>status</b>: <span title="Codes:{https://spor.ema.europa.eu/v1/lists/200000005003 200000005004}">Current</span></p><p><b>combinedPharmaceuticalDoseForm</b>: <span title="Codes:{https://spor.ema.europa.eu/v1/lists/200000000004~200000000006~200000000007~200000000008 100000073839}">Inhalation powder</span></p><p><b>indication</b>: </p><div><p>Ventilastin Novolizer 100 mikrogram/dos, inhalationspulver är godkänt för vuxna, ungdomar och barn mellan 6 och 12 år. Symtomatisk behandling av tillstånd med åtföljande reversibel luftvägsobstruktion, t.ex. astma eller kroniskt obstruktiv lungsjukdom (KOL) med en betydande reversibilitetskomponent. Förebyggande av astmaanfall som utlöses av ansträngning eller exponering för allergen.</p>
</div><p><b>legalStatusOfSupply</b>: <span title="Codes:{https://spor.ema.europa.eu/v1/lists/100000072051 100000072084}">Medicinal product subject to medical prescription</span></p><p><b>classification</b>: <span title="Codes:{https://spor.ema.europa.eu/v1/lists/100000093533 100000098065}">salbutamol</span></p><blockquote><p><b>name</b></p><p><b>productName</b>: Ventilastin Novolizer 100 mikrogram/dos inhalationspulver</p><blockquote><p><b>part</b></p><p><b>part</b>: Ventilastin Novolizer</p><p><b>type</b>: <span title="Codes:{http://spor.ema.europa.eu/v1/lists/220000000000 220000000002}">Invented name part</span></p></blockquote><blockquote><p><b>part</b></p><p><b>part</b>: 100 mikrogram/dos</p><p><b>type</b>: <span title="Codes:{http://spor.ema.europa.eu/v1/lists/220000000000 220000000004}">Strength part</span></p></blockquote><blockquote><p><b>part</b></p><p><b>part</b>: inhalationspulver</p><p><b>type</b>: <span title="Codes:{http://spor.ema.europa.eu/v1/lists/220000000000 220000000005}">Pharmaceutical dose form part</span></p></blockquote><h3>Usages</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Country</b></td><td><b>Language</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{https://spor.ema.europa.eu/v1/lists/100000000002 100000000535}">Kingdom of Sweden</span></td><td><span title="Codes:{urn:ietf:bcp:47 sv}">Swedish</span></td></tr></table></blockquote></div>
</text>
<identifier>
<system value="http://ema.europa.eu/fhir/mpId"/>
<value value="SE-100001594-00012324"/>
</identifier>
<identifier>
<system value="http://ema.europa.eu/fhir/eurdId"/>
<value value="10330"/>
</identifier>
<domain>
<coding>
<system value="https://spor.ema.europa.eu/v1/lists/100000000004"/>
<code value="100000000012"/>
<display value="Human use"/>
</coding>
</domain>
<status>
<coding>
<system value="https://spor.ema.europa.eu/v1/lists/200000005003"/>
<code value="200000005004"/>
<display value="Current"/>
</coding>
</status>
<combinedPharmaceuticalDoseForm>
<coding>
<system
value="https://spor.ema.europa.eu/v1/lists/200000000004~200000000006~200000000007~200000000008"/>
<code value="100000073839"/>
<display value="Inhalation powder"/>
</coding>
</combinedPharmaceuticalDoseForm>
<indication
value="Ventilastin Novolizer 100 mikrogram/dos, inhalationspulver är godkänt för vuxna, ungdomar och barn mellan 6 och 12 år. Symtomatisk behandling av tillstånd med åtföljande reversibel luftvägsobstruktion, t.ex. astma eller kroniskt obstruktiv lungsjukdom (KOL) med en betydande reversibilitetskomponent. Förebyggande av astmaanfall som utlöses av ansträngning eller exponering för allergen."/>
<legalStatusOfSupply>
<coding>
<system value="https://spor.ema.europa.eu/v1/lists/100000072051"/>
<code value="100000072084"/>
<display
value="Medicinal product subject to medical prescription"/>
</coding>
</legalStatusOfSupply>
<classification>
<coding>
<system value="https://spor.ema.europa.eu/v1/lists/100000093533"/>
<code value="100000098065"/>
<display value="salbutamol"/>
</coding>
</classification>
<name>
<productName
value="Ventilastin Novolizer 100 mikrogram/dos inhalationspulver"/>
<part>
<part value="Ventilastin Novolizer"/>
<type>
<coding>
<system
value="http://spor.ema.europa.eu/v1/lists/220000000000"/>
<code value="220000000002"/>
<display value="Invented name part"/>
</coding>
</type>
</part>
<part>
<part value="100 mikrogram/dos"/>
<type>
<coding>
<system
value="http://spor.ema.europa.eu/v1/lists/220000000000"/>
<code value="220000000004"/>
<display value="Strength part"/>
</coding>
</type>
</part>
<part>
<part value="inhalationspulver"/>
<type>
<coding>
<system
value="http://spor.ema.europa.eu/v1/lists/220000000000"/>
<code value="220000000005"/>
<display value="Pharmaceutical dose form part"/>
</coding>
</type>
</part>
<usage>
<country>
<coding>
<system
value="https://spor.ema.europa.eu/v1/lists/100000000002"/>
<code value="100000000535"/>
<display value="Kingdom of Sweden"/>
</coding>
</country>
<language>
<coding>
<system value="urn:ietf:bcp:47"/>
<code value="sv"/>
<display value="Swedish"/>
</coding>
</language>
</usage>
</name>
</MedicinalProductDefinition>
</resource>
</entry>
<entry>
<fullUrl
value="https://hl7-eu.github.io/unicom-ig/branches/mpd-r4b/RegulatedAuthorization/VentilastinNovolizer100mginhaspul-SE-PLC-RA"/>
<resource>
<RegulatedAuthorization>
<id value="VentilastinNovolizer100mginhaspul-SE-PLC-RA"/>
<meta>
<profile
value="http://unicom-project.eu/fhir/StructureDefinition/PPLRegulatedAuthorization"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="RegulatedAuthorization_VentilastinNovolizer100mginhaspul-SE-PLC-RA"> </a><p class="res-header-id"><b>Generated Narrative: RegulatedAuthorization VentilastinNovolizer100mginhaspul-SE-PLC-RA</b></p><a name="VentilastinNovolizer100mginhaspul-SE-PLC-RA"> </a><a name="hcVentilastinNovolizer100mginhaspul-SE-PLC-RA"> </a><a name="hcVentilastinNovolizer100mginhaspul-SE-PLC-RA-en-US"> </a><p><b>identifier</b>: <code>http://ema.europa.eu/fhir/marketingAuthorizationNumber</code>/24458</p><p><b>subject</b>: <a href="MedicinalProductDefinition-VentilastinNovolizer100mginhaspul-SE-PLC-MPD.html">MedicinalProductDefinition: identifier = http://ema.europa.eu/fhir/mpId#SE-100001594-00012324,http://ema.europa.eu/fhir/eurdId#10330; domain = Human use; status = Current; combinedPharmaceuticalDoseForm = Inhalation powder; indication = Ventilastin Novolizer 100 mikrogram/dos, inhalationspulver är godkänt för vuxna, ungdomar och barn mellan 6 och 12 år. Symtomatisk behandling av tillstånd med åtföljande reversibel luftvägsobstruktion, t.ex. astma eller kroniskt obstruktiv lungsjukdom (KOL) med en betydande reversibilitetskomponent. Förebyggande av astmaanfall som utlöses av ansträngning eller exponering för allergen.; legalStatusOfSupply = Medicinal product subject to medical prescription; classification = salbutamol</a></p><p><b>type</b>: <span title="Codes:{https://spor.ema.europa.eu/v1/lists/220000000060 220000000061}">Marketing Authorisation</span></p><p><b>region</b>: <span title="Codes:{https://spor.ema.europa.eu/v1/lists/100000000002 100000000535}">Kingdom of Sweden</span></p><p><b>status</b>: <span title="Codes:{https://spor.ema.europa.eu/v1/lists/100000072049 100000072099}">Valid</span></p><p><b>statusDate</b>: 2008-02-15</p><p><b>holder</b>: <a href="Organization-LOC-100001591.html">Organization Meda AB</a></p><h3>Cases</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Type</b></td><td><b>Date[x]</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{https://ema.europa.eu/fhir/authorisationDateType dateOfFirstAuthorisation}">First Authorisation</span></td><td>2008-02-15</td></tr></table></div>
</text>
<identifier>
<system
value="http://ema.europa.eu/fhir/marketingAuthorizationNumber"/>
<value value="24458"/>
</identifier>
<subject>🔗
<reference
value="MedicinalProductDefinition/VentilastinNovolizer100mginhaspul-SE-PLC-MPD"/>
</subject>
<type>
<coding>
<system value="https://spor.ema.europa.eu/v1/lists/220000000060"/>
<code value="220000000061"/>
<display value="Marketing Authorisation"/>
</coding>
</type>
<region>
<coding>
<system value="https://spor.ema.europa.eu/v1/lists/100000000002"/>
<code value="100000000535"/>
<display value="Kingdom of Sweden"/>
</coding>
</region>
<status>
<coding>
<system value="https://spor.ema.europa.eu/v1/lists/100000072049"/>
<code value="100000072099"/>
<display value="Valid"/>
</coding>
</status>
<statusDate value="2008-02-15"/>
<holder>🔗
<reference value="Organization/LOC-100001591"/>
</holder>
<case>
<type>
<coding>
<system
value="https://ema.europa.eu/fhir/authorisationDateType"/>
<code value="dateOfFirstAuthorisation"/>
<display value="First Authorisation"/>
</coding>
</type>
<dateDateTime value="2008-02-15"/>
</case>
</RegulatedAuthorization>
</resource>
</entry>
<entry>
<fullUrl
value="https://hl7-eu.github.io/unicom-ig/branches/mpd-r4b/PackagedProductDefinition/VentilastinNovolizer100mginhaspul-SE-PLC-PPD"/>
<resource>
<PackagedProductDefinition>
<id value="VentilastinNovolizer100mginhaspul-SE-PLC-PPD"/>
<meta>
<profile
value="http://unicom-project.eu/fhir/StructureDefinition/PPLPackagedProductDefinition"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="PackagedProductDefinition_VentilastinNovolizer100mginhaspul-SE-PLC-PPD"> </a><p class="res-header-id"><b>Generated Narrative: PackagedProductDefinition VentilastinNovolizer100mginhaspul-SE-PLC-PPD</b></p><a name="VentilastinNovolizer100mginhaspul-SE-PLC-PPD"> </a><a name="hcVentilastinNovolizer100mginhaspul-SE-PLC-PPD"> </a><a name="hcVentilastinNovolizer100mginhaspul-SE-PLC-PPD-en-US"> </a><p><b>identifier</b>: <code>http://ema.europa.eu/example/pcid</code>/?ngen-9?</p><p><b>packageFor</b>: <a href="MedicinalProductDefinition-VentilastinNovolizer100mginhaspul-SE-PLC-MPD.html">MedicinalProductDefinition: identifier = http://ema.europa.eu/fhir/mpId#SE-100001594-00012324,http://ema.europa.eu/fhir/eurdId#10330; domain = Human use; status = Current; combinedPharmaceuticalDoseForm = Inhalation powder; indication = Ventilastin Novolizer 100 mikrogram/dos, inhalationspulver är godkänt för vuxna, ungdomar och barn mellan 6 och 12 år. Symtomatisk behandling av tillstånd med åtföljande reversibel luftvägsobstruktion, t.ex. astma eller kroniskt obstruktiv lungsjukdom (KOL) med en betydande reversibilitetskomponent. Förebyggande av astmaanfall som utlöses av ansträngning eller exponering för allergen.; legalStatusOfSupply = Medicinal product subject to medical prescription; classification = salbutamol</a></p><p><b>containedItemQuantity</b>: 1 Cartridge<span style="background: LightGoldenRodYellow"> (Details: 200000000014 code200000002114 = '200000002114')</span></p><p><b>description</b>: </p><div><p>Kasett 1 x 200 doser (refill)</p>
</div><h3>MarketingStatuses</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Country</b></td><td><b>Status</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{https://spor.ema.europa.eu/v1/lists/100000000002 100000000535}">Kingdom of Sweden</span></td><td><span title="Codes:{https://spor.ema.europa.eu/v1/lists/100000072052 100000072083}">Marketed</span></td></tr></table><blockquote><p><b>packaging</b></p><p><b>type</b>: <span title="Codes:{https://spor.ema.europa.eu/v1/lists/100000073346 100000073498}">Box</span></p><p><b>quantity</b>: 1</p><p><b>material</b>: <span title="Codes:{https://spor.ema.europa.eu/v1/lists/200000003199 200000003529}">Cardboard</span></p><blockquote><p><b>containedItem</b></p><h3>Items</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Reference</b></td></tr><tr><td style="display: none">*</td><td><a href="ManufacturedItemDefinition-VentilastinNovolizer100mginhaspul-SE-PLC-MID.html">ManufacturedItemDefinition: status = active; manufacturedDoseForm = Inhalation powder; unitOfPresentation = Cartridge</a></td></tr></table><p><b>amount</b>: 1 Cartridge<span style="background: LightGoldenRodYellow"> (Details: 100000110633~200000000014 code200000002114 = '200000002114')</span></p></blockquote></blockquote></div>
</text>
<identifier>
<system value="http://ema.europa.eu/example/pcid"/>
</identifier>
<packageFor>🔗
<reference
value="MedicinalProductDefinition/VentilastinNovolizer100mginhaspul-SE-PLC-MPD"/>
</packageFor>
<containedItemQuantity>
<value value="1"/>
<unit value="Cartridge"/>
<system value="http://spor.ema.europa.eu/v1/lists/200000000014"/>
<code value="200000002114"/>
</containedItemQuantity>
<description value="Kasett 1 x 200 doser (refill)"/>
<marketingStatus>
<country>
<coding>
<system
value="https://spor.ema.europa.eu/v1/lists/100000000002"/>
<code value="100000000535"/>
<display value="Kingdom of Sweden"/>
</coding>
</country>
<status>
<coding>
<system
value="https://spor.ema.europa.eu/v1/lists/100000072052"/>
<code value="100000072083"/>
<display value="Marketed"/>
</coding>
</status>
</marketingStatus>
<packaging>
<type>
<coding>
<system
value="https://spor.ema.europa.eu/v1/lists/100000073346"/>
<code value="100000073498"/>
<display value="Box"/>
</coding>
</type>
<quantity value="1"/>
<material>
<coding>
<system
value="https://spor.ema.europa.eu/v1/lists/200000003199"/>
<code value="200000003529"/>
<display value="Cardboard"/>
</coding>
</material>
<containedItem>
<item>
<reference>🔗
<reference
value="ManufacturedItemDefinition/VentilastinNovolizer100mginhaspul-SE-PLC-MID"/>
</reference>
</item>
<amount>
<value value="1"/>
<unit value="Cartridge"/>
<system
value="http://spor.ema.europa.eu/v1/lists/100000110633~200000000014"/>
<code value="200000002114"/>
</amount>
</containedItem>
</packaging>
</PackagedProductDefinition>
</resource>
</entry>
<entry>
<fullUrl
value="https://hl7-eu.github.io/unicom-ig/branches/mpd-r4b/ManufacturedItemDefinition/VentilastinNovolizer100mginhaspul-SE-PLC-MID"/>
<resource>
<ManufacturedItemDefinition>
<id value="VentilastinNovolizer100mginhaspul-SE-PLC-MID"/>
<meta>
<profile
value="http://unicom-project.eu/fhir/StructureDefinition/PPLManufacturedItemDefinition"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><a name="ManufacturedItemDefinition_VentilastinNovolizer100mginhaspul-SE-PLC-MID"> </a><p class="res-header-id"><b>Generated Narrative: ManufacturedItemDefinition VentilastinNovolizer100mginhaspul-SE-PLC-MID</b></p><a name="VentilastinNovolizer100mginhaspul-SE-PLC-MID"> </a><a name="hcVentilastinNovolizer100mginhaspul-SE-PLC-MID"> </a><a name="hcVentilastinNovolizer100mginhaspul-SE-PLC-MID-en-US"> </a><p><b>status</b>: Active</p><p><b>manufacturedDoseForm</b>: <span title="Codes:{https://spor.ema.europa.eu/v1/lists/200000000004 100000073839}">Inhalation powder</span></p><p><b>unitOfPresentation</b>: <span title="Codes:{https://spor.ema.europa.eu/v1/lists/200000000014 200000002114}">Cartridge</span></p></div>
</text>
<status value="active"/>
<manufacturedDoseForm>
<coding>
<system value="https://spor.ema.europa.eu/v1/lists/200000000004"/>
<code value="100000073839"/>
<display value="Inhalation powder"/>
</coding>
</manufacturedDoseForm>
<unitOfPresentation>
<coding>
<system value="https://spor.ema.europa.eu/v1/lists/200000000014"/>
<code value="200000002114"/>
<display value="Cartridge"/>
</coding>
</unitOfPresentation>
</ManufacturedItemDefinition>
</resource>
</entry>
</Bundle>
IG © 2022+ UNICOM. Package hl7.eu.fhir.ufis-swe-unicom#0.1.0 based on FHIR 5.0.0. Generated 2024-06-28
Links: Table of Contents |
QA Report
The UNICOM Innovation Action has received funding from the European Union's Horizon 2020
research and innovation programme under grant agreement No. 875299.
